# Pueraria tuberosa **Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/pueraria-tuberosa **Data Source:** Hermetica Superfoods Ingredient Encyclopedia **Updated:** 2026-03-19 **Evidence Score:** 6 / 10 **Category:** Ayurveda **Also Known As:** Pueraria tuberosa, Indian Kudzu, Vidarikand, Vidari, Bhoomi Kumara, Wild Potato, PT ## Overview Pueraria tuberosa contains isoflavones like puerarin and genistein that modulate estrogen receptors and [glucose metabolism](/ingredients/condition/weight-management) pathways. Research primarily focuses on its potential lactogenic effects and blood sugar management properties. ## Health Benefits • May enhance lactation by increasing prolactin levels (shown in animal studies only - no human trials) • Potentially protects against diabetic kidney disease by reducing [blood glucose](/ingredients/condition/weight-management) and kidney damage markers (preclinical evidence only) • Demonstrates [anti-inflammatory](/ingredients/condition/inflammation) effects through reduction of [lipid peroxidation](/ingredients/condition/antioxidant) and C-reactive protein (rat model studies) • Shows anticancer potential against colon cancer cells at 63.91 µg/ml concentration (in vitro evidence only) • Traditional use as immune booster and reproductive health support (no modern clinical validation) ## Mechanism of Action Pueraria tuberosa's isoflavones, particularly puerarin and genistein, bind to estrogen receptors (ERα and ERβ) to stimulate prolactin production in mammary tissues. The compounds also activate AMPK pathways and inhibit α-glucosidase enzymes, improving glucose uptake and reducing blood sugar spikes. [Anti-inflammatory](/ingredients/condition/inflammation) effects occur through NF-κB pathway inhibition and cytokine modulation. ## Clinical Summary Current evidence for Pueraria tuberosa is limited to animal studies and in vitro research, with no published human clinical trials. Animal studies show 40-60% increases in milk yield and prolactin levels in lactating rats. Preclinical diabetes studies demonstrate 25-35% reductions in [blood glucose](/ingredients/condition/weight-management) and improved kidney function markers in diabetic rats. Human efficacy, optimal dosing, and safety profiles remain unestablished due to lack of clinical trials. ## Nutritional Profile Pueraria tuberosa (Indian Kudzu) tuber composition per 100g dry weight: Carbohydrates constitute the dominant macronutrient at approximately 70-75g, primarily as starch and complex polysaccharides. Protein content ranges from 4-6g, containing amino acids including puerarin-associated peptide fractions. Crude fiber is estimated at 3-5g. Fat content is minimal at 0.5-1.5g. Moisture in fresh tubers is approximately 60-70%. Key bioactive isoflavones include puerarin (daidzein-8-C-glucoside) at approximately 1.2-3.5mg/g dry extract, daidzein at 0.8-2.1mg/g, and formononetin at trace to 0.5mg/g — these phytoestrogens are the primary pharmacologically active constituents. Steroidal saponins (tuberosin and related compounds) are present at approximately 0.5-2% of dry weight and are considered responsible for galactagogue and [adaptogen](/ingredients/condition/stress)ic effects. Pueraroside and tuberosin glycosides contribute to [antioxidant activity](/ingredients/condition/antioxidant). Mineral content includes moderate potassium (estimated 300-450mg/100g dry), calcium (approximately 80-120mg/100g dry), magnesium (approximately 40-70mg/100g dry), and trace iron and zinc. Vitamin content is limited but includes small amounts of B-complex vitamins. Bioavailability of isoflavones is enhanced by gut microbial conversion; puerarin exhibits relatively high oral bioavailability (~30-40%) compared to other isoflavones. Starch digestibility is moderate. Note: Quantitative data largely derived from phytochemical extraction studies; standardized nutritional analyses on whole tuber are sparse in published literature. ## Dosage & Preparation Animal studies used: Puerarin 15 mg/kg/day, aqueous extract 150 mg/kg/day, or 10-40 mg per 100g body weight for [anti-inflammatory](/ingredients/condition/inflammation) effects. No human dosage data available. No standardization markers established. Consult a healthcare provider before starting any new supplement. ## Safety & Drug Interactions Safety data for Pueraria tuberosa in humans is insufficient due to lack of clinical trials. Theoretical concerns include hormonal interactions due to estrogenic isoflavones, particularly in hormone-sensitive conditions like breast or uterine cancer. May interact with diabetes medications by enhancing blood sugar-lowering effects, requiring monitoring. Pregnancy and breastfeeding safety is unknown despite traditional use for lactation support. ## Scientific Research All available evidence comes from preclinical animal models and in vitro studies - no human clinical trials, RCTs, or meta-analyses were identified. Key studies include rat models showing puerarin at 15 mg/kg/day increased milk yield and prolactin levels comparable to domperidone, and PTY-2 fraction reversing diabetic nephropathy markers in streptozotocin-induced diabetic rats. ## Historical & Cultural Context Pueraria tuberosa has been used traditionally in Ayurvedic medicine as a spermatogenic agent, immune booster, and aphrodisiac. The plant has also been investigated for traditional contraceptive applications in various animal models. ## Synergistic Combinations Fenugreek, Blessed Thistle, Shatavari, Ashwagandha, Moringa ## Frequently Asked Questions ### What is the recommended dosage of Pueraria tuberosa for lactation? No standardized human dosage exists for Pueraria tuberosa as clinical trials have not been conducted. Traditional Ayurvedic preparations typically use 3-6 grams of root powder daily, but safety and efficacy at these doses remain unverified in nursing mothers. ### Can Pueraria tuberosa lower blood sugar levels? Animal studies suggest Pueraria tuberosa may reduce blood glucose by 25-35% through α-glucosidase inhibition and improved insulin sensitivity. However, no human studies confirm these effects, and diabetic patients should consult healthcare providers before use. ### Is Pueraria tuberosa safe during pregnancy? Safety during pregnancy is unknown due to lack of human studies. The plant's estrogenic isoflavones could theoretically affect hormonal balance during pregnancy, making medical supervision essential before use. ### What are the active compounds in Pueraria tuberosa? The primary bioactive compounds are isoflavones including puerarin, genistein, daidzein, and genistin. These compounds are responsible for the plant's estrogenic, anti-diabetic, and anti-inflammatory properties demonstrated in laboratory studies. ### How long does Pueraria tuberosa take to increase milk production? Animal studies show increased prolactin levels within 7-14 days of administration. However, no human trials exist to confirm timing or effectiveness for lactation enhancement, making evidence purely theoretical for nursing mothers. ### Does Pueraria tuberosa interact with diabetes medications? Pueraria tuberosa may have blood sugar-lowering potential based on preclinical studies, which could theoretically increase the effect of diabetes medications like metformin or insulin. If you are taking diabetes medications, consult your healthcare provider before using Pueraria tuberosa supplements to avoid potential hypoglycemia or dosage adjustments. Current evidence is limited to animal studies, so medical supervision is important for safe concurrent use. ### What is the difference between Pueraria tuberosa and Pueraria mirifica for breast health? Pueraria tuberosa is traditionally used in Ayurvedic medicine primarily to support lactation through potential prolactin elevation, while Pueraria mirifica (from Thailand) is marketed mainly for menopausal symptoms and phytoestrogen content. Pueraria tuberosa's lactation benefits are supported only by animal studies with no human clinical trials, whereas both species have limited human evidence overall. They are botanically distinct plants with different traditional uses, so their effects and safety profiles may differ. ### Who should avoid taking Pueraria tuberosa supplements? Women with hormone-sensitive cancers, those taking hormonal contraceptives, and individuals with uncontrolled diabetes should avoid Pueraria tuberosa without medical guidance, as it may affect hormone and blood glucose levels. Pregnant women should not use it due to insufficient safety data, and those allergic to legumes (Pueraria is in the pea family) should exercise caution. Anyone taking medications should consult a healthcare provider before supplementing, as interactions have not been thoroughly studied in humans. --- *Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com* *License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*